Dermatology and Therapy (Jul 2020)

A Review of Current Keloid Management: Mainstay Monotherapies and Emerging Approaches

  • Emily E. Limmer,
  • Donald A. Glass

DOI
https://doi.org/10.1007/s13555-020-00427-2
Journal volume & issue
Vol. 10, no. 5
pp. 931 – 948

Abstract

Read online

Abstract Commonly affecting those with skin of color, keloids are an aberrant wound response that leads to wound tissue expanding above and beyond the original cutaneous injury. Keloids are notoriously and particularly difficult to treat because of their tendency to recur after excision. The current standard of care is intralesional steroid (triamcinolone acetonide). However, because no therapy has yet proven to be fully curative, keloid treatments have expanded to include a number of options, from injections to multimodal approaches. This review details current treatment of keloids with injections (bleomycin, verapamil, hyaluronic acid and hyaluronidase, botulinum toxin, and collagenase), cryotherapy, laser, radiofrequency ablation, radiation, extracorporeal shockwave therapy, pentoxifylline, and dupilumab.

Keywords